文 献1）Morrell NW, Adnot S, Archer SL, Dupuis J, Lloyd Jones P, MacLean MR, et al. Cellular and molecular basis of pulmonary arterial hypertension. J Am Coll Cardiol 2009; 54(1 Suppl): S20-S31.3）Maarman G, Lecour S, Butrous G, Thienemann F, Sliwa K: A comprehensive review: the evolution of animal models in pulmonary hypertension research; are we there yet? Pulm Circ 2013; 3(4): 739-56.4）Carman BL, Predescu DN, Machado R, Predescu SA: Plexiform Arteriopathy in Rodent Models of Pulmonary Arterial Hypertension. Am J Pathol 2019; 189(6): 1133-44.5）Ogawa A, Nakamura K, Matsubara H, Fujio H, Ikeda T, Kobayashi K, et al. Prednisolone inhibits proliferation of cultured pulmonary artery smooth muscle cells of patients with idiopathic pulmonary arterial hypertension. Circulation 2005; 112(12): 1806-12.6）Perros F, Montani D, Dorfmüller P, Durand-Gasselin I, Tcherakian C, Le Pavec J, et al. Platelet-derived growth factor expression and function in idiopathic pulmonary arterial hypertension. Am J Respir Crit Care Med 2008; 178(1): 81-8.7）Andrae J, Gallini R, Betsholtz C: Role of platelet-derived growth factors in physiology and medicine. Genes Dev 2008; 22(10): 1276-312.2）Stenmark KR, Meyrick B, Galie N, Mooi WJ, McMurtry IF: Animal models of pulmonary arterial hypertension: the hope for etiological discovery and pharmacological cure. Am J Physiol Lung Cell Mol Physiol 2009; 297(6): L1013-32.8）Schermuly RT, Dony E, Ghofrani HA, Pullamsetti S, Savai R, Roth M, et al. Reversal of experimental pulmonary hypertension by PDGF inhibition. J Clin Invest 2005; 115(10): 2811-21.9）Morii C, Tanaka HY, Izushi Y, Nakao N, Yamamoto M, Matsubara H, et al. 3D in vitro model of vascular medial thickening in pulmonary arterial hypertension. Front Bioeng Biotechnol 2020; 8: 482.10）Tanaka HY, Kitahara K, Sasaki N, Nakao N, Sato K, Narita H, et al. Pancreatic stellate cells derived from human pancreatic cancer demonstrate aberrant SPARC-dependent ECM remodeling in 3D engineered fibrotic tissue of clinically relevant thickness. Biomaterials 2019; 192: 355-67.11）Ghofrani HA, Morrell NW, Hoeper MM, Olschewski H, Peacock AJ, Barst RJ, et al. Imatinib in pulmonary arterial hypertension patients with inadequate response to established therapy. Am J Respir Crit Care Med 2010; 182(9): 1171-7.12）Ten Freyhaus H, Berghausen EM, Janssen W, Leuchs M, Zierden M, Murmann K, et al. Genetic Ablation of PDGF-Dependent Signaling Pathways Abolishes Vascular Remodeling and Experimental Pulmonary Hypertension. Arterioscler Thromb Vasc Biol 2015; 35(5): 1236-45.13）Yu J, Seldin MM, Fu K, Li S, Lam L, Wang P, et al. Topological Arrangement of Cardiac Fibroblasts Regulates Cellular Plasticity. Circ Res 2018; 123(1): 73-85.169
元のページ ../index.html#185